Healthcare provider profile · identity verified

Matthew C. Poling, M.D.

Family Practice · COLLEGE STATION, TX · NPI 1922069327

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	367	104
Levothyroxine Sodium	Levothyroxine Sodium	238	68
Pantoprazole Sodium	Pantoprazole Sodium	232	72
Amlodipine Besylate	Amlodipine Besylate	228	73
Lisinopril	Lisinopril	214	68
Metoprolol Succinate	Metoprolol Succinate	206	62
Losartan Potassium	Losartan Potassium	179	61
Gabapentin	Gabapentin	164	46
Tramadol Hcl	Tramadol Hcl	162	29
Rosuvastatin Calcium	Rosuvastatin Calcium	147	49
Spironolactone	Spironolactone	143	48
Celecoxib	Celecoxib	139	39
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	128	41
Alprazolam	Alprazolam	123	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	116	25
Duloxetine Hcl	Duloxetine Hcl	110	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	107	34
Potassium Chloride	Potassium Chloride	104	36
Metformin Hcl	Metformin Hcl	102	37
Trazodone Hcl	Trazodone Hcl	101	33
Carvedilol	Carvedilol	89	28
Metformin Hcl Er	Metformin Hcl	89	31
Omeprazole	Omeprazole	80	25
Ozempic	Semaglutide	78	13
Sertraline Hcl	Sertraline Hcl	78	21
Hydrochlorothiazide	Hydrochlorothiazide	77	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	75	28
Glipizide Er	Glipizide	74	19
Simvastatin	Simvastatin	74	24
Fluticasone Propionate	Fluticasone Propionate	71	29
Bupropion Xl	Bupropion Hcl	69	24
Tizanidine Hcl	Tizanidine Hcl	68	20
Furosemide	Furosemide	65	24
Pravastatin Sodium	Pravastatin Sodium	65	20
Tamsulosin Hcl	Tamsulosin Hcl	56	17
Quetiapine Fumarate	Quetiapine Fumarate	55	suppressed
Clopidogrel	Clopidogrel Bisulfate	54	16
Eliquis	Apixaban	54	13
Jardiance	Empagliflozin	49	17
Pregabalin	Pregabalin	48	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	45	13
Esomeprazole Magnesium	Esomeprazole Magnesium	44	15
Ramipril	Ramipril	44	13
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	42	15
Zolpidem Tartrate	Zolpidem Tartrate	42	13
Acetaminophen-Codeine	Acetaminophen With Codeine	40	suppressed
Lorazepam	Lorazepam	40	12
Mirtazapine	Mirtazapine	39	13
Carisoprodol	Carisoprodol	37	suppressed
Famotidine	Famotidine	34	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	33	suppressed
Allopurinol	Allopurinol	32	11
Atenolol	Atenolol	32	suppressed
Ondansetron Odt	Ondansetron	32	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	31	16
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Cephalexin	Cephalexin	29	24
Ketoconazole	Ketoconazole	29	15
Finasteride	Finasteride	28	suppressed
Ibuprofen	Ibuprofen	28	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Topiramate	Topiramate	26	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	11
Glipizide	Glipizide	25	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	12
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	25	suppressed
Azelastine Hcl	Azelastine Hcl	24	suppressed
Irbesartan	Irbesartan	24	suppressed
Montelukast Sodium	Montelukast Sodium	24	suppressed
Glimepiride	Glimepiride	23	11
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Acyclovir	Acyclovir	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	14
Tolterodine Tartrate Er	Tolterodine Tartrate	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Estradiol	Estradiol	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Azithromycin	Azithromycin	18	15
Meloxicam	Meloxicam	18	suppressed
Methylprednisolone	Methylprednisolone	18	12
Prednisone	Prednisone	18	14
Triamcinolone Acetonide	Triamcinolone Acetonide	18	13
Baclofen	Baclofen	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Valsartan	Valsartan	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	13
Gemfibrozil	Gemfibrozil	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Naproxen	Naproxen	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Torsemide	Torsemide	14	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Glyburide-Metformin Hcl	Glyburide/Metformin Hcl	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Methimazole	Methimazole	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error